Protagonist Therapeutics, Inc Shareholders' Equity
Protagonist Therapeutics, Inc (PTGX) had Shareholders' Equity of $841.54 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $841.54M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $655.47M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $614.71M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $645.44M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $841.54M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $655.47M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $614.71M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $645.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $668.02M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $689.05M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $675.29M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $531.91M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $541.32M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $560.44M 10-Q · filed 2025-08-06 |
| 2023-12-31 | $336.68M 10-K · filed 2026-02-25 |
| 2023-09-30 | $302.15M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $294.07M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $216.17M 10-Q · filed 2024-08-06 |
| 2022-12-31 | $215.61M 10-K · filed 2026-02-25 |
| 2022-09-30 | $243.62M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $267.98M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $301.78M 10-Q · filed 2023-08-03 |
| 2021-12-31 | $300.02M 10-K · filed 2025-02-21 |
| 2021-09-30 | $329.66M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $357.45M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $259.33M 10-Q · filed 2022-08-04 |
| 2020-12-31 | $279.61M 10-K · filed 2024-02-27 |
| 2020-09-30 | $169.59M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $167.49M 10-Q · filed 2021-11-03 |
| 2020-03-31 | $62.67M 10-Q · filed 2021-08-04 |
| 2019-12-31 | $79.96M 10-K · filed 2023-03-15 |
| 2019-09-30 | $95.36M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $84.32M 10-Q · filed 2020-11-04 |
| 2019-03-31 | $100.83M 10-Q · filed 2020-08-06 |
| 2018-12-31 | $112.52M 10-K · filed 2022-02-28 |
| 2018-09-30 | $123.96M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $107.66M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $114.62M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $120.63M 10-K · filed 2021-03-10 |
| 2017-09-30 | $57.84M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $61.03M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $74.89M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $87.56M 10-K · filed 2020-03-10 |
| 2016-09-30 | $97.49M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$46.20M 10-Q · filed 2016-09-15 |
| 2015-12-31 | -$27.40M 10-K · filed 2019-03-12 |
| 2014-12-31 | -$12.62M 10-K · filed 2018-03-07 |
| 2013-12-31 | -$1.39M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |